Intra-Cellular Therapies Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Hello, everyone. Welcome to Bank of America 2021 Virtual Health Care Conference. My name is Ashwani Verma. I cover biotech companies here at Bank of America. The next company on our virtual stage is Intra-Cellular Therapies. And joining me today from Intra-Cellular is Dr. Sharon Mates and Mark Neumann.
Sharon, just I think it would be helpful if you can give a brief overview of the company before we get into the Q&A session.
Great. Thanks, Ash. It's a pleasure to be here today to tell you our story. First, I will be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ. I refer you to our website and to our SEC filings for updates on the company.
I know many of you know us, but let me start with just a brief background on our company. Intra-Cellular Therapies was founded in 2002, using technology-based
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
